Artificial intelligence disease detection and care coordination platform Viz.ai has launched the first agentic platform for health systems to build and deploy their own customizable care pathways.
The newly announced Viz Agent Studio will allow systems to create AI pathways within the Viz platform. The tool allows healthcare organizations to translate clinical guidelines into workflows, then deploy and scale them "across the enterprise using natural language," executives said.
“This model of an AI care pathway at scale is very powerful,” Viz.ai CEO and co-founder Chris Mansi, M.D., told Fierce Healthcare.
“If you reduce variation to guideline-based care, outcomes improve dramatically,” Mansi said.
Improved clinical and financial outcomes from such pathways have been observed in multiple conditions, according to Mansi, from reducing length of stay by three days in stroke conditions and lowering readmissions in chronic obstructive pulmonary disease (COPD).
“Agentic AI is obviously the future of every industry,” Mansi said. “But in healthcare, it's so needed because today, so few patients are treated by guidelines.”
Research has shown that clinical practice guidelines are not always routinely followed. While drivers vary, a 2022 study, in particular, found primary care clinicians need 26.7 hours per day to follow national recommended guidelines for preventive care.
The new tool from Viz.ai looks to change that.
Healthcare professionals can speak or type into Viz Agent Studio to specify a condition and potential testing or treatments, according to Mansi. The AI will then run through clinical guidelines to create a customizable care pathway.
“Once they build the pathway, we have an internal validation and verification step before we then essentially work with the hospital to launch it with their IT system,” Mansi said.
Viz Agent Studio is available to health systems using the Viz platform, according to Mansi. Camden, N.J.-based Cooper University Health Care is one health system using the new capabilities.
Co-CEO of Cooper University Health Care Anthony Mazzarelli, M.D., said in a statement that clinical standardization has "always been one of the hardest problems to solve in medicine."
“We’ve had the guidelines and the evidence,” Mazzarelli said. “What’s been missing is a reliable way to embed those standards into everyday workflows. Viz Agent Studio has the potential to help change that.”
Mansi said Viz.ai has been focused on improving clinician workflow since the company launched in 2016. Viz.ai’s stroke detection tool was approved by the FDA in 2018.
Since then, its platform has been deployed at 2,000 hospitals across the U.S., a scale that Mansi said covers “two-thirds” of the country’s population.
“It's never just been a tool for neurosurgeons or radiologists, it’s for the entire patient journey,” Mansi said. "It's always been truly agentic."